Name: Miolocard solution for injections 100 mg/ml. 5 ml. ampoules №10
Availability: InStock

Miolocard (meldonium) solution for injections 100 mg/ml. 5 ml. ampoules №10

$38.00

Miolocard is prescribed in complex therapy: with ischemic heart disease (including angina pectoris, myocardial infarction); with chronic heart failure; with dyshormonal cardiomyopathy; with retinal hemorrhage; with acute / chronic disorders of cerebral blood supply (cerebrovascular insufficiency, strokes); with hemophthalmos (vitreous hemorrhage); with thrombosis of the central retinal vein, its branches; with retinopathy (diabetic, hypertensive); with reduced working capacity, physical overstrain (including athletes); with withdrawal syndrome (in the complex treatment of alcoholism).

Category: Cardiovascular

Description

Description

Miolocard composition
active substance: 3- (2,2,2-trimethylhydrazinium) propionate dihydrate (meldonium);
1 ml of solution contains 3- (2,2,2-trimethylhydrazinium) propionate dihydrate (meldonium) 100 mg;
excipient: water for injection.

Dosage form
Injection.

Pharmacological properties
It is a remedy that improves metabolic processes. The drug restores the balance between the need for oxygen and its delivery to the cells, eliminates the accumulated toxic products of cellular metabolism. Also has a tonic effect. In the case of heart failure, it increases the contractility of the myocardium, reduces the incidence of angina attacks, and increases exercise tolerance. In case of cerebral circulation ischemic disorders, it improves blood flow in the ischemic focus, promotes blood redistribution in favor of the area suffering from a lack of oxygen. The drug helps to eliminate functional disorders of the nervous system.

Indications
Miolocard is prescribed in complex therapy:

with ischemic heart disease (including angina pectoris, myocardial infarction);
with chronic heart failure;
with dyshormonal cardiomyopathy;
with retinal hemorrhage;
with acute / chronic disorders of cerebral blood supply (cerebrovascular insufficiency, strokes);
with hemophthalmos (vitreous hemorrhage);
with thrombosis of the central retinal vein, its branches;
with retinopathy (diabetic, hypertensive);
with reduced working capacity, physical overstrain (including athletes);
with withdrawal syndrome (in the complex treatment of alcoholism).

Contraindications
Miolocard should not be prescribed:

with intolerance to the components;
with increased intracranial pressure (with impaired venous outflow, the growth of intracranial tumors).

Children
There is insufficient data on the use of the drug in children.

Application during pregnancy and lactation
The safety of use during these periods has not been proven.

Method of administration and dosage
Miolocard is administered intravenously.

For cardiovascular diseases, 500–1000 mg / day is indicated. The standard course is 4-6 weeks.
For cardialgia (pain in the heart) against the background of dyshormonal myocardial dystrophy – 500 mg / day. Standard course – 12 days.
In acute disorders of cerebral circulation, 500–1000 mg / day is indicated. The general course is 4-6 weeks. For chronic – 500 mg / day, course – 4-6 weeks.
For mental / physical overload, 500 mg / day is indicated, the course of treatment is 10-14 days. If necessary, repeat therapy in 2-3 weeks.
Athletes are prescribed 500-1000 mg / day before exercise. Duration of taking Myolocard in the preparatory period is 14–21 days, in the competitive period – 10–14 days.
In chronic alcoholism, 500–1000 mg / day is prescribed, the course of treatment is 7–10 days.

Repeated courses (2-3 times a year) are allowed after consultation with a doctor.
In view of the stimulating effect, the medicine is recommended to be taken in the morning.

Overdose
Overdose cases are not known. The drug is low-toxic and does not cause adverse reactions dangerous to human health, even in case of an overdose.
Possible symptoms: drop in blood pressure, tachycardia, agitation.
Treatment is symptomatic.

Side effects:

Immune disorders: allergies (angioedema, dermatitis, anaphylaxis).
Mental disorders: agitation, fear, obsessive thoughts, sleep disorders.
Neurological disorders: paresthesia, tremor, hypesthesia, headache, tinnitus, gait disturbance, vertigo, loss of consciousness.
Cardiac disorders: changes in heart rhythm (tachycardia, arrhythmia, fibrillation), palpitations, chest discomfort, increase / decrease in blood pressure, hypotensive crisis.
Respiratory disorders: infections, pharyngitis, cough, dis / apnea.
Digestive disorders: dyspepsia, metallic taste in the mouth, appetite disturbances, nausea, flatulence, stool disorders, abdominal pain, dry mouth, hypersalivation.
Skin changes: pallor of the skin, hyperemia, rashes, itching.
Musculoskeletal disorders: back pain, myasthenia gravis, muscle spasms.
Urinary disorders: pollakiuria.
General disorders: weakness, chills, edema, asthenia, hot / cold sensations, cold sweat.
Changes in laboratory tests: dyslipidemia, increased levels of C-reactive protein, abnormalities in the ECG, eosinophilia.